\
&
Contact us
\
&
Contact us
Starts in 3 days from now
LocationBelgrade, Serbia
Under the title “Empowering society through climate services” and hosted by the Center for the Promotion of Science, this event offers a unique opportunity to foster collaboration and strengthen the climate services community in Eastern Europe.
It will bring together experts, policymakers, and innovators to explore the design, use, quality, and standardisation of climate services. Expect engaging talks, hands-on workshops, interactive discussions, and artistic exhibitions, including the winning project from the second Climateurope2 Art+Science call.
The programme features discussions on key topics such as agriculture, health, and the Mission Adaptation to Climate change in the region.
A Marketplace will provide space for networking and engaging in creative, participatory activities.
Find out more about this event and register via this page.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment EIT
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
